As explained in the introduction section, CCR5Δ32 exerts its protective effect against HIV infection through two mechanisms: reduced expression of the CCR5 gene (gene-dosage effect; probably the most important mechanism) (60, 63) and sequestration of CCR5 and CXCR4 from the cell surface (65, 66). The gene discussed is CCR5; the disease is HIV infectious disease.